Glia is a clinical-stage drug platform company with a patented technology that enables existing drugs to act through unique neural pathways. Our most advanced drug product, Pro-ocular™, treats ocular surface disease by engaging the central nervous system to secrete the body’s tear film, relieve ocular discomfort, reduce blurry vision, decrease ocular inflammation, and nourish ocular tissue to promote healing.